ENTRADA THERAPEUTICS, INC. Active Patents
8 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-03-28: Application 18620636; Invention COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY; Applicant Entrada Therapeutics, Inc.; Status Patented Case.
- 2022-06-15: Application 17757421; Invention COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS; Applicant Entrada Therapeutics, Inc.; Status Patented Case.
- 2022-06-10: Application 17806395; Invention SYNTHESIS OF FMOC-PROTECTED MORPHOLINO MONOMERS AND OLIGOMERS; Applicant Entrada Therapeutics, Inc.; Status Patented Case.
- 2021-10-06: Application 17495238; Invention COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY; Applicant Entrada Therapeutics, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-28 | 18620636 | COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY | Entrada Therapeutics, Inc. | Patented Case | 2026-08-04 | 12698482 | US20250115885A1 | Natarajan SETHURAMAN Jason RUTH Louis A. TARTAGLIA Dehua PEI Ziqing QIAN | United States United States United States United States United States | MEAH, MOHAMMAD Y |
| 2022-06-15 | 17757421 | COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS | Entrada Therapeutics, Inc. | Patented Case | 2026-09-22 | 12741989 | US20230020092A1 | Ziqing Qian Xiang Li Mahboubeh Kheirabadi Mohanraj Dhanabal Haoming Liu Xiulong Shen Kimberli Kamer Natarajan Sethuraman | United States United States United States United States United States United States United States United States | BEANE, RANDALL L |
| 2022-06-10 | 17806395 | SYNTHESIS OF FMOC-PROTECTED MORPHOLINO MONOMERS AND OLIGOMERS | Entrada Therapeutics, Inc. | Patented Case | 2025-08-05 | 12378267 | US20230097585A1 | Kyle A. Totaro Ziqing Qian | United States United States | KENYON, JOHN S |
| 2021-10-06 | 17495238 | COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY | Entrada Therapeutics, Inc. | Patented Case | 2024-05-21 | 11987821 | US20220033787A1 | Natarajan SETHURAMAN Jason RUTH Louis A. TARTAGLIA Dehua PEI Ziqing QIAN | United States United States United States United States United States | MEAH, MOHAMMAD Y |
| 2020-04-20 | 16852615 | CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF | Entrada Therapeutics, Inc. | Patented Case | 2022-01-18 | 11225506 | US20200385427A1 | Dehua PEI Ziqing QIAN | United States United States | KATAKAM, SUDHAKAR |
| 2020-03-17 | 16821018 | COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY | Entrada Therapeutics, Inc. | Patented Case | 2021-11-09 | 11168310 | US20200354697A1 | Natarajan SETHURAMAN Jason RUTH Lou A. TARTAGLIA Dehua PEI Ziqing QIAN | United States United States United States United States United States | MEAH, MOHAMMAD Y |
| 2016-11-23 | 15360719 | CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF | Entrada Therapeutics, Inc. | Patented Case | 2020-10-27 | 10815276 | US20170355730A1 | Dehua PEI Ziqing QIAN | United States United States | KATAKAM, SUDHAKAR |
| 2016-11-21 | 15312878 | CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF | Entrada Therapeutics, Inc. | Patented Case | 2020-04-21 | 10626147 | US20170190743A1 | Dehua PEI Ziqing QIAN | United States United States | KATAKAM, SUDHAKAR |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |